ImprimisRx Latanoprost PF 0.005% Eye Drops Recall: Non-Pharmaceutical Ingredient Risk
ImprimisRx recalls 0.005% Latanoprost PF eye drops compounded for professionals due to use of non-pharmaceutical grade PEG 40 Castor Oil. This may pose safety risks for users.
Recall notice
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Contact the company
What happened, in plain English
ImprimisRx is recalling 0.005% Latanoprost PF eye drops in 5ml bottles because they used non-pharmaceutical grade PEG 40 Castor Oil. This could cause safety issues for people using the drops. Read more at govinfonow.com/recall/41537-imprimisrx-latanoprost-pf-0-005-eye-drops-recall-non-pharmaceutical.
Source Summary by GovInfoNow · govinfonow.com/recall/41537-imprimisrx-latanoprost-pf-0-005-eye-drops-recall-non-pharmaceutical · Updated October 8, 2026 · FDA enforcement record: FDA #D-1131-2017
Cite this page
“ImprimisRx Latanoprost PF 0.005% Eye Drops Recall: Non-Pharmaceutical Ingredient Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41537-imprimisrx-latanoprost-pf-0-005-eye-drops-recall-non-pharmaceutical. Based on FDA recall #D-1131-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1131-2017%22&limit=1).
Why it’s dangerous
The drops contain non-pharmaceutical grade PEG 40 Castor Oil, which was mistakenly used by the supplier. This ingredient may not be safe for eye use and could cause adverse reactions.
Who’s affected
Patients and healthcare professionals who received these compounded eye drops from ImprimisRx. Those with specific eye conditions may be at higher risk.
How to tell if you have this one
Check for 5ml bottles labeled 'Latanoprost PF Solution, 0.005%, Ophthalmic Drops' compounded by ImprimisRx. The batch number 0404017@32B was used from October 1, 2017.
- Brand
ImprimisRx- Category
Drug
All 4 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1130-2017 | Curcumin Emulsion 10mg/ml Injection, Sterile 10 mL Multiple Dose Vial, For Slow IV Administration, Compounded for a licensed professional or patient use by ImprimisRx, Irvine, CA; 03212017@21B Exp:6/19/2017; 03232017@19B Exp:6/21/2017; 03292017@27B Exp:6/27/2017; 03292017@9B Exp:6/27/2017; 04042017@21B Exp:7/3/2017; 04122017@22B Exp:7/11/2017; 04132017@14B Exp:7/12/2017; 04192017@37B Exp:7/18/2017; 04192017@17B Exp:7/18/2017; 04242017@18B Exp:7/23/2017 | 2608 vials |
| D-1131-2017 | Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA; 0404017@32B, 10/01/2017 | 19 bottles |
| D-1132-2017 | Timolol-Latanoprost PF Solution (0.5-0.005)%, Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA; 04042017@34B, 10/01/2017 | 16 bottles |
| D-1133-2017 | Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA; 05092017@2B, 11/5/2017 | 2 bottles |
What to do — step by step
Check Product Details
Look for the batch number 0404017@32B on the bottle label, which was used from October 1, 2017.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1131-2017 (June 23, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1131-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.